Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Newtyn Management, LLC
Form 13F · Q2 2026

Newtyn Management, LLC

CIK 1569241Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$801M
Reported book value
34
Positions
12
Quarters on record
Top 50
Positions

Newtyn Management, LLC — holdings

Top 34 positions of 34, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1QDEL Quidelortho Corp6.6M+45.3%$116M14.5%
2THERAVANCE BIOPHARMA INC Theravance Biopharma Inc3.4M−29.1%$58M7.3%
3INDIVIOR PHARMACEUTICALS INC Indivior Pharmaceuticals Inc1.3M−34.7%$54M6.7%
4CNNE Cannae Hldgs Inc3.2M−3.0%$46M5.7%
5PAR Par Technology Corp2.4M−11.5%$42M5.3%
6WEAVE COMMUNICATIONS INC Weave Communications Inc6.8M−3.0%$41M5.1%
7TFX Teleflex Incorporated305,000−23.8%$39M4.8%
8AIV Apartment Invt & Mgmt Co12.2M+0.0%$36M4.5%
9MAGN Magnera Corp2.8M+1.4%$33M4.1%
10OCTV Octave Intelligence Plc1.9M—$31M3.9%
11XOMA ROYALTY CORPORATION Xoma Royalty Corporation709,247—$30M3.8%
12RHLD Resolute Hldgs Mgmt Inc202,423−16.5%$29M3.7%
13BV Brightview Hldgs Inc1.9M−7.6%$27M3.4%
14PSIX Power Solutions Intl Inc600,890—$23M2.9%
15CCOI Cogent Comm Holdings Inc1.7M+3.5%$23M2.9%
16AD Array Digital Infrastructure597,090−63.1%$22M2.7%
17COMP Compass Minerals Intl Inc632,326−17.9%$20M2.5%
18GDOT Green Dot Corp1.2M+743.7%$16M2.0%
19SPB Spectrum Brands Holdings Inc185,012+0.0%$16M2.0%
20XRN Chiron Real Estate Inc406,414—$15M1.9%
21RCKT Rocket Pharmaceuticals Inc4.0M+26.3%$14M1.7%
22FLWS 1 800 Flowers Com Inc3.5M+0.0%$12M1.5%
23NODK Ni Hldgs Inc670,000+0.0%$11M1.3%
24GRAL Grail Inc150,000+0.0%$10M1.3%
25NVRI Enviri Corp374,194—$8M1.0%
26ATAIBECKLEY INC Ataibeckley Inc1.2M−33.3%$6M0.8%
27SRG Seritage Growth Pptys2.3M+5411.3%$6M0.7%
28ELMES Elme Communities2.5M+705.8%$4M0.5%
29FSP Franklin Str Pptys Corp7.2M+0.0%$4M0.5%
30VCX Fundrise Innovation Fd Llc40,000—$3M0.4%
31ZOOZ Zooz Strategy Ltd537,499—$3M0.4%
32WVE Wave Life Sciences Ltd215,000−28.3%$1M0.2%
33MREO Mereo Biopharma Group Plc3.0M−57.6%$953,1000.1%
34ENHA Enhanced Group Inc99,998—$286,9940.0%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.